OTC Markets OTCQB - Delayed Quote USD

CV Sciences, Inc. (CVSI)

Compare
0.0500 +0.0025 (+5.26%)
At close: October 14 at 4:00 PM EDT
Loading Chart for CVSI
DELL
  • Previous Close 0.0475
  • Open 0.0475
  • Bid 0.0451 x --
  • Ask 0.0474 x --
  • Day's Range 0.0475 - 0.0475
  • 52 Week Range 0.0300 - 0.1000
  • Volume 10,000
  • Avg. Volume 219,870
  • Market Cap (intraday) 9.033M
  • Beta (5Y Monthly) 0.60
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0200
  • Earnings Date Nov 12, 2024 - Nov 18, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

CV Sciences, Inc. develops, manufactures, markets, and sells herbal supplements and hemp-based cannabidiol (CBD) in North America. The company offers its products under the PlusCBD, ProCBD, HappyLane, and PlusCBD Pet brands in the health care market sector, including nutraceutical, beauty care, specialty foods, and pet products through its websites, select distributors, brick and mortar retailers, and select e-tailers. It is also developing cannabinoids intended to treat medical indications, including CVSI-007 that combines CBD and nicotine for the treatment of smokeless tobacco use and addiction. The company was formerly known as CannaVest Corp. and changed its name to CV Sciences, Inc. in January 2016. CV Sciences, Inc. was incorporated in 2010 and is based in San Diego, California.

www.cvsciences.com

42

Full Time Employees

December 31

Fiscal Year Ends

Recent News: CVSI

View More

Performance Overview: CVSI

Trailing total returns as of 10/14/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

CVSI
25.00%
S&P 500
22.85%

1-Year Return

CVSI
25.00%
S&P 500
35.40%

3-Year Return

CVSI
78.26%
S&P 500
34.28%

5-Year Return

CVSI
97.46%
S&P 500
97.28%

Compare To: CVSI

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CVSI

View More

Valuation Measures

Annual
As of 10/14/2024
  • Market Cap

    8.38M

  • Enterprise Value

    8.40M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.47

  • Price/Book (mrq)

    3.34

  • Enterprise Value/Revenue

    0.53

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -15.95%

  • Return on Assets (ttm)

    -12.51%

  • Return on Equity (ttm)

    -78.97%

  • Revenue (ttm)

    15.85M

  • Net Income Avi to Common (ttm)

    -2.53M

  • Diluted EPS (ttm)

    -0.0200

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    477k

  • Total Debt/Equity (mrq)

    19.78%

  • Levered Free Cash Flow (ttm)

    -112.75k

Research Analysis: CVSI

View More

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 3.95M
Earnings -584k
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Company Insights: CVSI

People Also Watch